NEW YORK — German biotech drug maker GPC Biotech AG said Thursday it reaffirmed its full-year revenue guidance and expects to implement cost-cutting measures, including a significant number of job cuts.
NEW YORK — German biotech drug maker GPC Biotech AG said Thursday it reaffirmed its full-year revenue guidance and expects to implement cost-cutting measures, including a significant number of job cuts.